文献速递产科母胎医学

37至39周分娩大于胎龄但非巨大儿的新生儿与母儿并发症的相关性

Maternal and Neonatal Morbidity Associated With Early Term Delivery of Large-for-Gestational-Age But Nonmacrosomic Neonates.
PubMed 文献 · Obstet Gynecol · 2019-01-01

结果显示此类分娩与母体复合并发症(6.27 vs 4.09/1,000活产;aRR 1.40,95%CI 1.25-1.56)及新生儿复合并发症(11.09 vs 6.07/1,000活产;aRR 1.47,95%CI 1.35-1.60)升高相关,分层分析结果一致。

要点

  • 37至39周分娩LGA但非巨大儿新生儿,母体复合并发症发生率为6.27/1,000活产,aRR 1.40(95%CI 1.25-1.56)。
  • 新生儿复合并发症发生率为11.09/1,000活产,aRR 1.47(95%CI 1.35-1.60)。
  • 按糖尿病分层后,母体及新生儿复合并发症风险升高仍持续存在。

核心结论

  • 在37至39周,分娩出生体重≥同胎龄90百分位但<4,000 g的新生儿与母体及新生儿复合并发症升高相关。

研究设计与样本

  • 回顾性队列研究,使用2011至2013年美国生命统计数据集。
  • 纳入标准为37至39周经产程分娩的单胎妊娠,新生儿无畸形,且为适龄或出生体重<4,000 g(该研究以4,000 g为巨大儿阈值)的LGA新生儿。
  • 采用多变量泊松回归模型计算校正相对风险(aRR)及95%CI。

主要发现

  • 母体复合并发症(输血、子宫破裂、非计划子宫切除、入住重症监护病房或非计划手术中任一项)发生率:非巨大儿LGA组6.27/1,000活产 vs 适龄组4.09/1,000活产;aRR 1.40,95%CI 1.25-1.56。
  • 新生儿复合并发症(5分钟Apgar评分<5、辅助通气>6小时、惊厥或严重神经功能障碍、显著产伤或新生儿死亡中任一项)发生率:非巨大儿LGA组11.09/1,000活产 vs 适龄组6.07/1,000活产;aRR 1.47,95%CI 1.35-1.60。
  • 按糖尿病分层分析后,母体及新生儿复合并发症风险升高均持续存在。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether, at 37-39 weeks of gestation, delivery of a neonate with a birth weight that is 90% or greater for gestational age but less than 4,000 g is associated with increased composite maternal and neonatal morbidity. METHODS: This retrospective cohort study used U.S. Vital Statistics datasets for the years 2011-2013. Inclusion criteria were singleton pregnancies delivered at 37-39 weeks of gestation after labor in which the neonates were nonanomalous, and either appropriate for gestational age or large for gestational age (LGA) neonates with birth weights of less than 4,000 g (our threshold for macrosomia). The coprimary outcomes were composite maternal morbidity (any of the following: maternal transfusion, ruptured uterus, unplanned hysterectomy, admission to intensive care unit, or unplanned procedure) and composite neonatal morbidity (any of the following: Apgar score less than 5 at 5 minutes, assisted ventilation for more than 6 hours, seizure or serious neurologic dysfunction, significant birth injury or neonatal mortality). Multivariable Poisson regression models were used to calculate adjusted relative risk (aRR) and 95% CI. RESULTS: Among the 3.9 million women who met inclusion criteria, 1.3% delivered neonates who were LGA but nonmacrosomic. The rate of composite maternal morbidity was 53% higher women who delivered nonmacrosomic LGA neonate (6.27 vs 4.09/1,000 live births; aRR 1.40, 95% CI 1.25-1.56). This increased risk of composite maternal morbidity persisted in analyses stratified by diabetes. The rate of composite neonatal morbidity was 83% higher for nonmacrosomic LGA neonates (11.09 vs 6.07/1,000 live births; aRR 1.47, 95% CI 1.35-1.60) and persisted in analyses stratified by diabetes. CONCLUSION: At 37-39 weeks of gestation, delivery of a neonate with a birth weight that is 90% or greater for gestational age but less than 4,000 g is associated with increased composite maternal and neonatal morbidity.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Doty MS, Chen HY, Sibai BM, et al. Maternal and Neonatal Morbidity Associated With Early Term Delivery of Large-for-Gestational-Age But Nonmacrosomic Neonates. Obstet Gynecol. 2019. PMID: 31135729. doi:10.1097/AOG.0000000000003285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。